Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A heavy metal baseline score predicts outcome in AML.

Ohanian M, Telouk P, Kornblau S, Albarede F, Ruvolo P, Tidwell RSS, Plesa A, Kanagal-Shamanna R, Matera EL, Cortes J, Carson A, Dumontet C.

Am J Hematol. 2020 Jan 16. doi: 10.1002/ajh.25731. [Epub ahead of print]

PMID:
31944361
2.

Juvenile Fibromyalgia and Headache Comorbidity in Children and Adolescents: A Literature Review.

Matera E, Palumbi R, Peschechera A, Petruzzelli MG, Sciruicchio V, de Tommaso M, Margari L.

Pain Res Manag. 2019 Jun 3;2019:3190829. doi: 10.1155/2019/3190829. eCollection 2019. Review.

3.

In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts.

Alameh G, Emptoz-Bonneton A, Rolland de Ravel M, Matera EL, Mappus E, Balaguer P, Rocheblave L, Lomberget T, Dumontet C, Le Borgne M, Pugeat M, Grenot C, Cuilleron CY.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):684-691. doi: 10.1080/14756366.2019.1575825.

4.

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.

Grasselly C, Denis M, Bourguignon A, Talhi N, Mathe D, Tourette A, Serre L, Jordheim LP, Matera EL, Dumontet C.

Front Immunol. 2018 Oct 9;9:2100. doi: 10.3389/fimmu.2018.02100. eCollection 2018.

5.

Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study.

Pascali M, Matera E, Craig F, Torre F, Giordano P, Margari F, Zagaria G, Margari M, Margari L.

Clin Child Psychol Psychiatry. 2019 Jul;24(3):433-445. doi: 10.1177/1359104518805800. Epub 2018 Oct 22.

6.

Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.

Dumontet C, Beck G, Gardebien F, Haudecoeur R, Mathé D, Matera EL, Tourette A, Mattei E, Esmenjaud J, Boyère C, Nurisso A, Peuchmaur M, Pérès B, Bouchaud G, Magnan A, Monneret G, Boumendjel A.

Eur J Med Chem. 2018 Oct 5;158:405-413. doi: 10.1016/j.ejmech.2018.09.033. Epub 2018 Sep 12.

PMID:
30237123
7.

Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.

Petruzzelli MG, Margari M, Peschechera A, de Giambattista C, De Giacomo A, Matera E, Margari F.

BMC Psychiatry. 2018 Aug 1;18(1):246. doi: 10.1186/s12888-018-1827-3.

8.

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.

Jordheim LP, Chettab K, Cros-Perrial E, Matera EL, Dumontet C.

Pharmacology. 2018;102(3-4):161-168. doi: 10.1159/000491587. Epub 2018 Jul 26.

PMID:
30048976
9.

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.

Sauveur J, Matera EL, Chettab K, Valet P, Guitton J, Savina A, Dumontet C.

Oncotarget. 2018 Apr 20;9(30):21141-21155. doi: 10.18632/oncotarget.24975. eCollection 2018 Apr 20.

10.

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding.

Hirz T, Matera EL, Chettab K, Jordheim LP, Mathé D, Evesque A, Esmenjaud J, Salles G, Dumontet C.

Oncotarget. 2017 Aug 18;8(42):72818-72834. doi: 10.18632/oncotarget.20350. eCollection 2017 Sep 22.

11.

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders.

Lamanna AL, Craig F, Matera E, Simone M, Buttiglione M, Margari L.

Neuropsychiatr Dis Treat. 2017 Jun 15;13:1559-1567. doi: 10.2147/NDT.S132214. eCollection 2017.

12.

Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues.

Matera E, Margari L, Palmieri VO, Zagaria G, Palumbi R, Margari F.

J Clin Psychopharmacol. 2017 Jun;37(3):302-309. doi: 10.1097/JCP.0000000000000688.

PMID:
28338545
13.

Deoxycholic acid derivatives as inhibitors of P-glycoprotein-mediated multidrug efflux.

Rocheblave L, de Ravel MR, Monniot E, Tavenard J, Cuilleron CY, Grenot C, Radix S, Matera EL, Dumontet C, Walchshofer N.

Steroids. 2016 Dec;116:5-12. doi: 10.1016/j.steroids.2016.09.017. Epub 2016 Sep 30.

PMID:
27697501
14.

Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies.

Cornet S, Mathé D, Chettab K, Evesque A, Matera EL, Trédan O, Dumontet C.

Mol Cancer Ther. 2016 Jun;15(6):1238-47. doi: 10.1158/1535-7163.MCT-15-0759. Epub 2016 Mar 17.

15.

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.

Duong MN, Cleret A, Matera EL, Chettab K, Mathé D, Valsesia-Wittmann S, Clémenceau B, Dumontet C.

Breast Cancer Res. 2015 Apr 24;17:57. doi: 10.1186/s13058-015-0569-0.

16.

Psychopathology, symptoms of attention-deficit/hyperactivity disorder, and risk factors in juvenile offenders.

Margari F, Craig F, Margari L, Matera E, Lamanna AL, Lecce PA, La Tegola D, Carabellese F.

Neuropsychiatr Dis Treat. 2015 Feb 10;11:343-52. doi: 10.2147/NDT.S75942. eCollection 2015.

17.

Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells.

de Ravel MR, Alameh G, Melikian M, Mahiout Z, Emptoz-Bonneton A, Matera EL, Lomberget T, Barret R, Rocheblave L, Walchshofer N, Beltran S, El Jawad L, Mappus E, Grenot C, Pugeat M, Dumontet C, Le Borgne M, Cuilleron CY.

J Med Chem. 2015 Feb 26;58(4):1832-45. doi: 10.1021/jm501676v. Epub 2015 Feb 11.

PMID:
25634041
18.

Overlap Between Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder: Searching for Distinctive/Common Clinical Features.

Craig F, Lamanna AL, Margari F, Matera E, Simone M, Margari L.

Autism Res. 2015 Jun;8(3):328-37. doi: 10.1002/aur.1449. Epub 2015 Jan 20.

19.

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies.

Duong MN, Matera EL, Mathé D, Evesque A, Valsesia-Wittmann S, Clémenceau B, Dumontet C.

MAbs. 2015;7(1):192-8. doi: 10.4161/19420862.2015.989020.

20.

Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.

Margari L, Matera E, Petruzzelli MG, Simone M, Lamanna AL, Pastore A, Palmieri VO, Margari F.

Int Clin Psychopharmacol. 2015 Mar;30(2):103-8. doi: 10.1097/YIC.0000000000000063.

21.

Aggression, impulsivity, and suicide risk in benign chronic pain patients - a cross-sectional study.

Margari F, Lorusso M, Matera E, Pastore A, Zagaria G, Bruno F, Puntillo F, Margari L.

Neuropsychiatr Dis Treat. 2014 Sep 2;10:1613-20. doi: 10.2147/NDT.S66209. eCollection 2014.

22.

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.

Jordheim LP, Cros-Perrial E, Matera EL, Bouledrak K, Dumontet C.

Clin Exp Pharmacol Physiol. 2014 Oct;41(10):817-24. doi: 10.1111/1440-1681.12282.

PMID:
25115435
23.

In vitro antileukaemic activity of extracts from Daphne gnidium leaves against sensitive and multidrug resistant K562/R7 cells.

Chaabane F, Krifa M, Matera E, Loussaeif A, Dijoux-Franca MG, Ghedira K, Dumontet C, Chekir-Ghedira L.

Tumour Biol. 2014 Sep;35(9):8991-8. doi: 10.1007/s13277-014-2129-0. Epub 2014 Jun 6.

PMID:
24903378
24.

Children with cochlear implants: cognitive skills, adaptive behaviors, social and emotional skills.

De Giacomo A, Craig F, D'Elia A, Giagnotti F, Matera E, Quaranta N.

Int J Pediatr Otorhinolaryngol. 2013 Dec;77(12):1975-9.

PMID:
24466572
25.

Neuropsychopathological comorbidities in learning disorders.

Margari L, Buttiglione M, Craig F, Cristella A, de Giambattista C, Matera E, Operto F, Simone M.

BMC Neurol. 2013 Dec 13;13:198. doi: 10.1186/1471-2377-13-198.

26.

Tolerability and safety profile of risperidone in a sample of children and adolescents.

Margari L, Matera E, Craig F, Petruzzelli MG, Palmieri VO, Pastore A, Margari F.

Int Clin Psychopharmacol. 2013 Jul;28(4):177-83. doi: 10.1097/YIC.0b013e328362497b.

PMID:
23689836
27.

Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.

Tagoug I, Jordheim LP, Herveau S, Matera EL, Huber AL, Chettab K, Manié S, Dumontet C.

Clin Cancer Res. 2013 Jul 1;19(13):3556-66. doi: 10.1158/1078-0432.CCR-12-3134. Epub 2013 May 14.

28.

Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells.

Jordheim LP, Barakat KH, Heinrich-Balard L, Matera EL, Cros-Perrial E, Bouledrak K, El Sabeh R, Perez-Pineiro R, Wishart DS, Cohen R, Tuszynski J, Dumontet C.

Mol Pharmacol. 2013 Jul;84(1):12-24. doi: 10.1124/mol.112.082347. Epub 2013 Apr 11.

PMID:
23580445
29.

Parents psychopathology of children with Attention Deficit Hyperactivity Disorder.

Margari F, Craig F, Petruzzelli MG, Lamanna A, Matera E, Margari L.

Res Dev Disabil. 2013 Mar;34(3):1036-43. doi: 10.1016/j.ridd.2012.12.001. Epub 2013 Jan 3.

PMID:
23291521
30.

Progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: design, synthesis, characterization and biological evaluation.

Zeinyeh W, Mahiout Z, Radix S, Lomberget T, Dumoulin A, Barret R, Grenot C, Rocheblave L, Matera EL, Dumontet C, Walchshofer N.

Steroids. 2012 Oct;77(12):1177-91. doi: 10.1016/j.steroids.2012.07.010. Epub 2012 Jul 31.

PMID:
22868178
31.

Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.

Maréchal R, Bachet JB, Mackey JR, Dalban C, Demetter P, Graham K, Couvelard A, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Rougier P, Penna C, André T, Dumontet C, Cass CE, Jordheim LP, Matera EL, Closset J, Salmon I, Devière J, Emile JF, Van Laethem JL.

Gastroenterology. 2012 Sep;143(3):664-674.e6. doi: 10.1053/j.gastro.2012.06.006. Epub 2012 Jun 13.

PMID:
22705007
32.

Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells.

Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C.

Mol Cancer Ther. 2011 Feb;10(2):303-12. doi: 10.1158/1535-7163.MCT-10-0568. Epub 2011 Jan 7.

33.

The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.

Arnaud O, Boumendjel A, Gèze A, Honorat M, Matera EL, Guitton J, Stein WD, Bates SE, Falson P, Dumontet C, Di Pietro A, Payen L.

Eur J Cancer. 2011 Mar;47(4):640-8. doi: 10.1016/j.ejca.2010.11.019. Epub 2011 Jan 7.

34.

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C.

BMC Cancer. 2010 Apr 12;10:135. doi: 10.1186/1471-2407-10-135.

35.

Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.

Saussede-Aim J, Matera EL, Herveau S, Rouault JP, Ferlini C, Dumontet C.

Anticancer Res. 2009 Aug;29(8):3003-9.

36.

Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.

Saussede-Aim J, Matera EL, Ferlini C, Dumontet C.

Cell Motil Cytoskeleton. 2009 Jul;66(7):378-88. doi: 10.1002/cm.20377.

PMID:
19466750
37.

Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.

Béghin A, Matera EL, Brunet-Manquat S, Dumontet C.

Cell Cycle. 2008 Oct;7(19):3074-82. Epub 2008 Oct 12.

PMID:
18818514
38.

Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.

Boumendjel A, Boccard J, Carrupt PA, Nicolle E, Blanc M, Geze A, Choisnard L, Wouessidjewe D, Matera EL, Dumontet C.

J Med Chem. 2008 Apr 10;51(7):2307-10. doi: 10.1021/jm0708331. Epub 2008 Feb 23.

PMID:
18293907
39.

Tobacco cessation treatment knowledge, attitudes and practices of Kentucky physicians.

Studts JL, Matera EL, Worth CT, Ghate SR, Miller BF 4th, Thomas SD, Sorrell CL.

J Ky Med Assoc. 2007 Oct;105(10):497-507.

PMID:
18038512
40.

ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.

Beghin A, Honore S, Messana C, Matera EL, Aim J, Burlinchon S, Braguer D, Dumontet C.

Exp Cell Res. 2007 Feb 1;313(3):473-85. Epub 2006 Oct 28.

PMID:
17188265
41.

Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein.

Raad I, Terreux R, Richomme P, Matera EL, Dumontet C, Raynaud J, Guilet D.

Bioorg Med Chem. 2006 Oct 15;14(20):6979-87. Epub 2006 Jul 7.

PMID:
16824763
42.
43.

Cholinergic suppression: a postsynaptic mechanism of long-term associative learning.

Morielli AD, Matera EM, Kovac MP, Shrum RG, McCormack KJ, Davis WJ.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4556-60.

44.

Learning: neural analysis in the isolated brain of a previously trained mollusc, Pleurobranchaea californica.

Kovac MP, Davis WJ, Matera EM, Morielli A, Croll RP.

Brain Res. 1985 Apr 8;331(2):275-84.

PMID:
3986570
46.
47.
48.

Organization of synaptic inputs to paracerebral feeding command interneurons of Pleurobranchaea californica. II. Inhibitory inputs.

Kovac MP, Davis WJ, Matera EM, Croll RP.

J Neurophysiol. 1983 Jun;49(6):1539-56. No abstract available.

PMID:
6875637
49.
50.

Functional and structural correlates of cell size in paracerebral neurons of Pleurobranchaea californica.

Kovac MP, Davis WJ, Matera E, Gillette R.

J Neurophysiol. 1982 May;47(5):909-27.

PMID:
7086475

Supplemental Content

Loading ...
Support Center